| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,470 |
3,617 |
$136K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,853 |
3,404 |
$110K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
6,644 |
5,834 |
$74K |
| 88307 |
|
981 |
782 |
$41K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
735 |
686 |
$33K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,446 |
1,154 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,806 |
3,360 |
$20K |
| 88141 |
|
1,917 |
1,703 |
$20K |
| 88304 |
|
1,005 |
851 |
$17K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
683 |
613 |
$15K |
| 80053 |
Comprehensive metabolic panel |
26,652 |
15,583 |
$15K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,900 |
1,641 |
$12K |
| 81513 |
|
271 |
215 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41,151 |
22,873 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,943 |
7,170 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
580 |
452 |
$7K |
| 88342 |
|
174 |
136 |
$4K |
| 87481 |
|
192 |
145 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,334 |
2,765 |
$4K |
| 81001 |
|
14,050 |
11,171 |
$2K |
| 84703 |
|
4,595 |
3,809 |
$2K |
| 87040 |
|
2,367 |
1,739 |
$2K |
| 83735 |
|
10,109 |
3,622 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,548 |
2,924 |
$2K |
| 83690 |
|
4,919 |
3,832 |
$1K |
| 86803 |
|
1,292 |
1,131 |
$1K |
| 83605 |
|
2,182 |
1,218 |
$1K |
| 84484 |
|
4,035 |
2,722 |
$975.54 |
| 80061 |
Lipid panel |
1,405 |
1,099 |
$860.59 |
| 85610 |
|
3,821 |
2,225 |
$762.12 |
| 82805 |
|
2,985 |
1,491 |
$711.90 |
| 82330 |
|
964 |
470 |
$643.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,213 |
1,037 |
$631.14 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,063 |
983 |
$550.92 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
999 |
817 |
$532.78 |
| 87077 |
|
1,378 |
1,102 |
$530.81 |
| 87486 |
|
847 |
787 |
$512.14 |
| 82962 |
|
9,144 |
2,716 |
$504.67 |
| 87581 |
|
849 |
789 |
$471.80 |
| 86850 |
|
3,622 |
2,873 |
$411.84 |
| 85027 |
|
4,809 |
2,269 |
$384.14 |
| 82247 |
|
1,989 |
872 |
$322.11 |
| 86900 |
|
6,155 |
5,019 |
$301.49 |
| 86901 |
|
6,238 |
5,079 |
$300.67 |
| 87186 |
|
658 |
529 |
$279.08 |
| 87340 |
|
1,416 |
1,243 |
$258.86 |
| 87210 |
|
930 |
828 |
$252.84 |
| 82550 |
|
478 |
372 |
$246.63 |
| 87070 |
|
427 |
309 |
$200.56 |
| 82950 |
|
1,108 |
471 |
$194.16 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
412 |
365 |
$189.54 |
| 86592 |
|
1,965 |
1,686 |
$181.36 |
| 86762 |
|
819 |
725 |
$152.56 |
| 81003 |
|
1,113 |
878 |
$151.20 |
| 80076 |
|
2,142 |
1,696 |
$139.37 |
| 87205 |
|
669 |
460 |
$132.96 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
87 |
84 |
$110.38 |
| 85730 |
|
1,658 |
1,138 |
$92.56 |
| 85060 |
|
35 |
27 |
$84.75 |
| 82150 |
|
152 |
129 |
$77.17 |
| 86140 |
|
2,635 |
1,654 |
$77.04 |
| 82553 |
|
692 |
511 |
$77.00 |
| 82570 |
|
489 |
376 |
$68.13 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
45 |
44 |
$63.52 |
| 82947 |
|
300 |
149 |
$39.54 |
| 82375 |
|
2,186 |
929 |
$36.13 |
| 84702 |
|
999 |
768 |
$31.80 |
| 86880 |
|
862 |
821 |
$31.75 |
| 84466 |
|
63 |
53 |
$26.74 |
| 82607 |
|
219 |
194 |
$26.73 |
| 87641 |
|
27 |
25 |
$26.25 |
| 82728 |
|
318 |
245 |
$22.71 |
| 84439 |
|
753 |
623 |
$22.58 |
| 84480 |
|
27 |
26 |
$21.00 |
| 83615 |
|
1,237 |
854 |
$16.20 |
| 87081 |
|
262 |
257 |
$15.33 |
| 83050 |
|
2,186 |
931 |
$13.97 |
| 85018 |
|
150 |
72 |
$12.36 |
| 82565 |
|
175 |
128 |
$12.22 |
| 84436 |
|
12 |
12 |
$10.08 |
| 82248 |
|
919 |
623 |
$8.76 |
| 87075 |
|
18 |
15 |
$8.55 |
| 82040 |
|
66 |
56 |
$6.96 |
| 82435 |
|
54 |
31 |
$0.81 |
| 84550 |
|
16 |
13 |
$0.65 |
| 84156 |
|
400 |
297 |
$0.00 |
| 85045 |
|
320 |
200 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
284 |
224 |
$0.00 |
| 84295 |
|
53 |
28 |
$0.00 |
| 83540 |
|
99 |
90 |
$0.00 |
| 82140 |
|
45 |
25 |
$0.00 |
| 80074 |
|
43 |
40 |
$0.00 |
| 84100 |
|
30 |
16 |
$0.00 |
| G9785 |
Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist |
14 |
12 |
$0.00 |
| 84145 |
|
35 |
29 |
$0.00 |
| 87653 |
|
17 |
12 |
$0.00 |
| 83525 |
|
36 |
12 |
$0.00 |
| 85384 |
|
26 |
14 |
$0.00 |
| 84132 |
|
37 |
25 |
$0.00 |
| 86920 |
|
246 |
179 |
$0.00 |
| 85652 |
|
540 |
417 |
$0.00 |
| 85379 |
|
143 |
30 |
$0.00 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
24 |
24 |
$0.00 |
| 82746 |
|
25 |
24 |
$0.00 |
| 80050 |
General health panel |
85 |
25 |
$0.00 |
| 82378 |
|
42 |
27 |
$0.00 |